
CBC is dedicated to the rapid communication of clinically relevant biomedical knowledge through a fast but rigorous editorial and peer-review pathway.
Its scope spans translational medicine, molecular and cellular biology, clinical biochemistry, genomics and epigenetics, proteomics and metabolomics, microbiome research, molecular oncology, neurobiology, biomarker discovery, drug discovery and resistance, gene and cell therapy, precision medicine, immunology, and vaccinology.
https://editorypress.uz/journal/clinical-and-biomedical-communications
imtiyaz.hassan@gmail.com
hassanlab@jmi.ac.in
https://hassanlab.in
Medicine & Health Sciences.
CBC focuses on translational medicine, molecular and cellular biology, genomics, proteomics, microbiome research, clinical biochemistry, biomarker discovery, drug discovery, precision medicine, immunology, vaccinology, public health, and clinically relevant biomedical technologies.
Electronic ISSN: 2345-2984
Print ISSN: Not specified on the public page
Public cite score and impact factor values were not listed on the source journal page.
CBC articles are published in an immediate open-access format.
The public journal policy states that article processing charges are FREE.
CBC emphasizes rapid editorial decision-making and accelerated online publication for clinically meaningful biomedical work.
Manuscripts are initially screened by the editors and, when suitable, typically sent to at least two reviewers in a single-blind peer review process.
© 2025 EditoryPress. Public Clinical and Biomedical Communications source data adapted for local rendering.
© 2026 EditoryPress. All rights reserved.